Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Column Group
Biotech
Judo throws down $100M to knock out kidney disease
Taking the mat is Judo Bio, a biotech armed with $100 million to develop oligonucleotide medicines targeting the kidney.
Gabrielle Masson
Oct 7, 2024 10:42am
Amgen-partnered Plexium snags $102M for protein degraders
Feb 23, 2022 8:00am
Appia Bio aims for new off-the-shelf CAR-T with $52M raise
May 11, 2021 5:15am
Remix debuts with $81M to 'reprogram' disease-causing RNA
Dec 8, 2020 7:15am
Nura Bio uncloaks with $73M and Biogen vet Alpna Seth as CEO
Jul 29, 2020 7:00am
Kallyope aims for the clinic with $112M raise
Mar 25, 2020 6:00am
